And I would also very much like to investigate whether this drug also works positively in patients with kidney damage without obesity
Auguet T, Berlanga A, Guiu-Jurado E, Martinez S, Porras JA, Aragones G, Sabench F, Hernandez M, Aguilar C, Sirvent JJ, Del Castillo D, Richart C (2014) Altered fatty acid metabolism-related gene expression in liver from morbidly obese women with non-alcoholic fatty liver disease
The test identifies predispositions in peptide metabolism genes (GLP1R, GIPR, MC4R, FTO) that may influence your metabolic response to GLP-1 therapy
The decision to prescribe semaglutide to patients on anticoagulation therapy should be individualized, considering the therapeutic benefits against the patient's baseline bleeding risk and comorbidity profile